These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33229923)

  • 1. Expanding the phenotype of PURA-related neurodevelopmental disorder: a close differential diagnosis of infantile hypotonia with psychomotor retardation and characteristic facies.
    Mishra S; Girisha KM; Shukla A
    Clin Dysmorphol; 2021 Jan; 30(1):1-5. PubMed ID: 33229923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders.
    Choi SA; Lee HS; Park TJ; Park S; Ko YJ; Kim SY; Lim BC; Kim KJ; Chae JH
    Brain Dev; 2021 Oct; 43(9):912-918. PubMed ID: 34116881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability.
    Hunt D; Leventer RJ; Simons C; Taft R; Swoboda KJ; Gawne-Cain M; ; Magee AC; Turnpenny PD; Baralle D
    J Med Genet; 2014 Dec; 51(12):806-13. PubMed ID: 25342064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient with a novel purine-rich element binding protein A mutation.
    Okamoto N; Nakao H; Niihori T; Aoki Y
    Congenit Anom (Kyoto); 2017 Nov; 57(6):201-204. PubMed ID: 28164378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular and Neuromuscular Junction Manifestations of the PURA-NDD: A Systematic Review of the Reported Symptoms and Potential Treatment Options.
    Mroczek M; Iyadurai S
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature.
    Reijnders MRF; Janowski R; Alvi M; Self JE; van Essen TJ; Vreeburg M; Rouhl RPW; Stevens SJC; Stegmann APA; Schieving J; Pfundt R; van Dijk K; Smeets E; Stumpel CTRM; Bok LA; Cobben JM; Engelen M; Mansour S; Whiteford M; Chandler KE; Douzgou S; Cooper NS; Tan EC; Foo R; Lai AHM; Rankin J; Green A; Lönnqvist T; Isohanni P; Williams S; Ruhoy I; Carvalho KS; Dowling JJ; Lev DL; Sterbova K; Lassuthova P; Neupauerová J; Waugh JL; Keros S; Clayton-Smith J; Smithson SF; Brunner HG; van Hoeckel C; Anderson M; Clowes VE; Siu VM; Ddd Study T; Selber P; Leventer RJ; Nellaker C; Niessing D; Hunt D; Baralle D
    J Med Genet; 2018 Feb; 55(2):104-113. PubMed ID: 29097605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the neurodevelopmental phenotype of PURA syndrome.
    Lee BH; Reijnders MRF; Abubakare O; Tuttle E; Lape B; Minks KQ; Stodgell C; Bennetto L; Kwon J; Fong CT; Gripp KW; Marsh ED; Smith WE; Huq AM; Coury SA; Tan WH; Solis O; Mehta RI; Leventer RJ; Baralle D; Hunt D; Paciorkowski AR
    Am J Med Genet A; 2018 Jan; 176(1):56-67. PubMed ID: 29150892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the PURA syndrome phenotype: A child with the recurrent PURA p.(Phe233del) pathogenic variant showing similarities with cutis laxa.
    Cinquina V; Ciaccio C; Venturini M; Masson R; Ritelli M; Colombi M
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1562. PubMed ID: 33275834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biallelic UNC80 mutations caused infantile hypotonia with psychomotor retardation and characteristic facies 2 in two Chinese patients with variable phenotypes.
    He Y; Ji X; Yan H; Ye X; Liu Y; Wei W; Xiao B; Sun Y
    Gene; 2018 Jun; 660():13-17. PubMed ID: 29572195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 25 Mainland Chinese cohort of patients with PURA-related neurodevelopmental disorders: clinical delineation and genotype-phenotype correlations.
    Dai W; Sun Y; Fan Y; Gao Y; Zhan Y; Wang L; Xiao B; Qiu W; Gu X; Sun K; Yu Y; Xu N
    Eur J Hum Genet; 2023 Jan; 31(1):112-121. PubMed ID: 36376392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new case with the recurrent PURA p.(Phe233del) pathogenic variant: Expansion of the phenotype and review of the literature.
    Ben Issa A; Ben Ayed I; Jallouli O; Souissi A; Bouchaalla W; Ben Said M; Mallouli S; Masmoudi S; Charfi Triki C; Hadj Kacem H; Kammoun F
    Int J Dev Neurosci; 2023 Jun; 83(4):383-395. PubMed ID: 37204304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel homozygous UNC80 variant in a child with infantile hypotonia with psychomotor retardation and characteristic facies-2 (IHPRF2).
    Obeid T; Hamzeh AR; Saif F; Nair P; Mohamed M; Al-Ali MT; Bastaki F
    Metab Brain Dis; 2018 Jun; 33(3):869-873. PubMed ID: 29430593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel
    Rodríguez-García ME; Cotrina-Vinagre FJ; Arranz-Canales E; Aragón AM; Hernández-Sánchez L; Rodríguez-Fornés F; Carnicero-Rodríguez P; Morales-Conejo M; Martín-Hernández E; Martínez-Azorín F
    J Genet; 2020; 99():. PubMed ID: 32089526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Complete Maternal Uniparental Disomy of Chromosome 2 With a Novel
    Tao Y; Han D; Wei Y; Wang L; Song W; Li X
    Front Genet; 2021; 12():747422. PubMed ID: 34594366
    [No Abstract]   [Full Text] [Related]  

  • 15. Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia.
    Muir AM; Gardner JF; van Jaarsveld RH; de Lange IM; van der Smagt JJ; Wilson GN; Dubbs H; Goldberg EM; Zitano L; Bupp C; Martinez J; Srour M; Accogli A; Alhakeem A; Meltzer M; Gropman A; Brewer C; Caswell RC; Montgomery T; McKenna C; McKee S; Powell C; Vasudevan PC; Brady AF; Joss S; Tysoe C; Noh G; Tarnopolsky M; Brady L; Zafar M; Schrier Vergano SA; Murray B; Sawyer L; Hainline BE; Sapp K; DeMarzo D; Huismann DJ; Wentzensen IM; Schnur RE; Monaghan KG; Juusola J; Rhodes L; Dobyns WB; Lecoquierre F; Goldenberg A; Polster T; Axer-Schaefer S; Platzer K; Klöckner C; Hoffman TL; MacArthur DG; O'Leary MC; VanNoy GE; England E; Varghese VC; Mefford HC
    Genet Med; 2021 May; 23(5):881-887. PubMed ID: 33473207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder.
    Millan F; Cho MT; Retterer K; Monaghan KG; Bai R; Vitazka P; Everman DB; Smith B; Angle B; Roberts V; Immken L; Nagakura H; DiFazio M; Sherr E; Haverfield E; Friedman B; Telegrafi A; Juusola J; Chung WK; Bale S
    Am J Med Genet A; 2016 Jul; 170(7):1791-8. PubMed ID: 27133397
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Falsaperla R; Sortino V; Schinocca MA; Fusto G; Rizzo R; Barberi C; Ruggieri M; Pappalardo XG
    Genes (Basel); 2024 Jun; 15(7):. PubMed ID: 39062627
    [No Abstract]   [Full Text] [Related]  

  • 18. PURA syndrome: neuromuscular junction manifestations with potential therapeutic implications.
    Qashqari H; McNiven V; Gonorazky H; Mendoza-Londono R; Hassan A; Kulkarni T; Amburgey K; Dowling JJ
    Neuromuscul Disord; 2022 Oct; 32(10):842-844. PubMed ID: 36210261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome sequencing identifies pathogenic variants of VPS13B in a patient with familial 16p11.2 duplication.
    Dastan J; Chijiwa C; Tang F; Martell S; Qiao Y; Rajcan-Separovic E; Lewis MES
    BMC Med Genet; 2016 Nov; 17(1):78. PubMed ID: 27832746
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.